Development of a diabetes prevention management program for clinical practice

Public Health Reports

Volumn 122, Issue 2, 2007, Pages 258-263

  Schwarz, Peter E H ^a   Schwarz, Jaqueline ^b   Schuppenies, Andrea ^a   Bornstein, Stefan R ^a   Schulze, Jan ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b TUMAINI   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; DIABETES CONTROL; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RESPONSIBILITY; GERMANY; HEALTH CARE QUALITY; HEALTH PROMOTION; LIFESTYLE; MOTIVATION; ORGANIZATION AND MANAGEMENT; PRIMARY PREVENTION; PROGRAM DEVELOPMENT; PUBLIC HEALTH; RISK ASSESSMENT; RISK FACTOR; SELF CARE;

DIABETES MELLITUS, TYPE 2; GERMANY; HEALTH PROMOTION; HUMANS; LIFE STYLE; MOTIVATION; NATIONAL HEALTH PROGRAMS; PRIMARY PREVENTION; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; RISK ASSESSMENT; RISK FACTORS; SELF CARE;

EID: 34047272825     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335490712200216     Document Type: Article

References (25)

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-787 (Pubitemid 34000780)
2. Alberti KG. Type 2 diabetes: questions of prevention. Diabetes Voice; Bulletin of the International Diabetes Federation 2002;47(4):5.
3. Zimmet P, Shaw J, Alberti KG. Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabet Med 2003;20:693-702. (Pubitemid 41701460)
4. Haffner SM. Can reducing peaks prevent type 2 diabetes: implication from recent diabetes prevention trials. Int J Clin Pract Suppl 2002(129):33-39
5. Liebl A, Goertz A, Henkel B, Spannheimer A. [Costly type 2 diabetes mellitus. Does diabetes cost 20 billion per year?] MMW Fortschr Med 2000;142(23):39-42.
6. Valensi P, Schwarz EH, Hall M, Felton AM, Maldonato A, Mathieu C. Pre-diabetes essential action: a European perspective. Diabetes Metab 2005;31:606-620 (Pubitemid 43001181)
7. Nestle M. Preventing childhood diabetes: the need for public health intervention. Am J Public Health 2005;95:1497-1499 (Pubitemid 41232939)
8. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998;317:703-713 (Pubitemid 28414300)
9. World Health Organization. Prevention of diabetes mellitus: report of a WHO Study Group. WHO Technical Report Series 1994;WHO Technical Report Series 844(ISBN 9241208449).
10. Hiltunen LA. Does glucose tolerance affect elderly persons' balance, gait or muscle strength? Cent Eur J Public Health 2001;9:22-25
11. Mayor S. Government publishes strategy to improve diabetes care. BMJ 2003;326:121.
12. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
13. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350
14. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trial Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002;359:2072-2077 (Pubitemid 34680970)
15. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-544
16. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004;27:155-161 (Pubitemid 38196725)
17. Watts G. Huge numbers must change lifestyle to prevent epidemic of diabetes. BMJ 2003;327:1365.
18. Narayan KM, Bowman BA, Engelgau ME. Prevention of type 2 diabetes. BMJ 2001;323:63-64 (Pubitemid 32681968)
19. Sartorelli DS, Sciarra EC, Franco LJ, Cardoso MA. Primary prevention of type 2 diabetes through nutritional counseling. Diabetes Care 2004;27:3019. (Pubitemid 39565083)
20. Weber I, Brenner G, Schwarz P, Schulze J. Mehr Evidenz - breitere Akzeptanz - erhöhte Chancen auf Umsetzung einer Maßnahme zur Prävention des Typ 2-Diabetes in Deutschland gesundheitsziele.de Berlin: Gesellschaft für Versicherungswissenschaft und-gestaltung e. V., 2005:239-245.
21. Schwarz P, Schwarz J, Bornstein S, Schulze J. Prevention of type 2 diabetes: what challenges do we have to address [cited 2006 Dec 21]. J Public Health 2005;2:296-303. Available from: URL: http://www.springerlink.com/content/ y8r0453ku55r2800/?p=14d5e26746fa4e1c892616f8e9e7ca87&pi=1
22. Schwarz P. [Targeted diabetes prevention in high risk groups: pro]. Dtsch Med Wochenschr 2005;130:1103.
23. Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003;26:725-731 (Pubitemid 36929335)
24. Roubideaux Y, Buchwald D, Beals J, Middlebrook D, Manson S, Muneta B, et al. Measuring the quality of diabetes care for older American Indians and Alaska natives. Am J Public Health 2004;94:60-65
25. Schulze J, Rothe U, Muller G, Kunath H. [Improvement of care for diabetics using the care model from Saxony]. Dtsch Med Wochenschr 2003;128:1161-1166